Hims & Hers to buy Australian digital health firm Eucalyptus in $1.15bn deal

19th Feb 2026 15:20

(Sharecast News) - Hims & Hers Health said on Thursday that it has agreed to buy Australian digital health firm Eucalyptus in a $1.15bn deal.

The US health and wellness platform said the deal accelerates its ability to bring access to high-quality, personalised care to more people across the world.

"As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada," it said.

Hims & Hers said it plans to expand its bench of local expertise and scale its infrastructure, making it possible for the company to reach millions more people globally with the model it has successfully built in the US.

Founder and chief executive Andrew Dudum said: "Healthcare challenges are global, and so is the demand for simpler, transparent, and more personalised healthcare. But how that comes to life looks different for every region and every person. We've shown the difference that makes in the US, and the logical next step is working with more international experts to make that difference abroad.

"With Eucalyptus, we will not only enter new markets, we will expand our ability to serve customers globally, trusting local experts to be a key part of how we transform healthcare into a customer-first, personalized industry. We believe this puts us on the path to becoming the leading global consumer health platform, where everyone can access the best care for their needs, regardless of where they live."

Hims & Hers was in the spotlight earlier this month after it said it was ditching plans to sell its own version of the Wegovy weight-loss drug, although that didn't stop Danish pharmaceuticals group Novo Nordisk from filing a lawsuit against the company for infringing on its patents.